Compound Deep-Dive
Cyclic Glycine-Proline
Niche IGF-1 regulator for brain health.
Hype Risk
4/10
Noticeability
4/10
Evidence Tier
Emerging
Cost / Month
~$45
What it's actually good for
How it works
Cyclic Glycine-Proline (cGP) is an endogenous metabolite of IGF-1 that regulates its bioavailability by competing with binding proteins. Emerging human evidence suggests it may support cognitive function, microcirculation, and blood pressure regulation, particularly in aging populations.
cGP acts as a competitive inhibitor for IGF-binding protein-3 (IGFBP-3), preventing it from sequestering IGF-1 and thereby increasing the levels of free, active IGF-1 in circulation.
Safety
- Generally well-tolerated as an endogenous molecule.
- Long-term safety of high-dose synthetic supplementation is not yet established.
- Consult a physician if you have conditions sensitive to IGF-1 levels.
The full StackRoast report adds
- The exact dose, timing, and effective range to actually run it at
- Where people go wrong with it — the dose-creep and timing traps
- What Cyclic Glycine-Proline clashes with or duplicates in your stack
Community Reality Check
Distilled from 65 threads
Community Reality Check
Distilled from 65 threadsWhat users report
- Mental clarity
- Improved focus
- Vascular health support
The catch
- Expensive
- Hard to source pure forms
- Subtle effects
Side effects reported
- None commonly reported
The Receipts
9 sources— studies, videos & links
The Receipts
9 sources— studies, videos & linksVideos
The New Rules for Aging Better, Smarter, and Sharper
Smarter Not Harder Podcast
An in-depth interview with Dr. Amanda Wiggins on the science of cGP and neurovascular aging.
Tiny Titans of Life: Unravelling Nature's Small Wonders
ResearchPod
Explains the role of Dr. Jian Guan's research in identifying cGP as a master regulator of IGF-1.
Papers
Creators
Clinical Sources
Taking Cyclic Glycine-Proline in a stack? Find out if the combination actually makes sense.
Roast My Stack →